The report looks at four possible scenarios including most notably the creation of a “grande Sécu...
Read moreThe Court has annulled the inclusion of the orphan drug Onivyde (irinotecan) in the reference price ...
Read moreThe association proposes concentrating efforts around four primary objectives.
Read moreAccording to the Institute for Quality and Efficiency in Health Care orphan drugs should undergo ear...
Read moreIn addition to new cancer drugs, the G-BA also evaluated the first antiviral drug to treat COVID-19 ...
Read moreNotably, the early access scheme was reformed with effect from 1st July 2021.
Read moreThe National Institute for Health and Care Excellence (NICE) on 31st January 2022 published its new ...
Read moreThe Ministry of Health reports that 65.1% of medicines admitted to reimbursement in 2021 were subjec...
Read moreThe passport is the entry point to the Innovative Licensing and Access Pathway (ILAP) which aims to ...
Read moreThis resolution includes proposed reforms to the market access (including pricing) landscape designe...
Read more